{"title":"Hypovitaminosis D and Type 2 Diabetes: What Correlation? Control Case Study about 110 Cases","authors":"S. Bellouk, S. Aziz, A. Chadli","doi":"10.12970/2310-9971.2018.06.02","DOIUrl":null,"url":null,"abstract":"Introduction : Relationship between diabetes and the (OH) vitamin D status raises several controversies; The aim of our study is to evaluate Vitamin D status in Moroccan type 2 diabetic women (DT2) by comparing it with a non-diabetic group (T). Secondary purpose was to establish relationships between Vitamine D status and T2D patients various metabolic, clinical and therapeutic parameters. Materials and Methods : This a cross-sectional case-control study including 110 patients with a Vitamin D dose (60 DT2 / 50 controls> 30 years). We excluded patients with a disease involving phosphocalcic metabolism or receiving Vitamin D supplementation or advanced renal or hepatic failure. Variables studied in the DT2 group were age, diabetes duration, glycemic equilibrium, BMI, degenerative complications, antidiabetic treatment, the menopause and vitamin D. Results were compared to a non-diabetic control group according to age, BMI and menopausal status. Results : Mean age was 51.5 ± 10.95 (DT2) vs 48.9 ± 11.2 years (T). Mean DT2 BMI was 32.1 vs 27.7 Kg / m 2 . Mean diabetes duration was 7.13 years with mean HBA1c at 9.17%. Hypovitaminosis D was present in 85% DT2, these results were comparable to the control group (84%). Mean level of Vitamin D was lower in the DT2 group: 17 ± 10.6 vs 22.2 ± 11.4 ng / ml (p = 0.005). 39% of TD2 were deficient vs 23% (T) p 35kg / m 2 (p= 0.003) with no significant relationship to age or menopausal status. In the DT2 group, there was a negative correlation between serum vitamin D levels and diabetes duration and BMI. Without relationship with HbA1c, degenerative complications or antidiabetic treatment. Conclusion : Hypovitaminosis D is as frequent in the diabetic population as in non-diabetic patients with lower rates and high prevalence in obese patients with ancient diabetes.","PeriodicalId":91903,"journal":{"name":"Journal of endocrinology and diabetes mellitus","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of endocrinology and diabetes mellitus","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12970/2310-9971.2018.06.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction : Relationship between diabetes and the (OH) vitamin D status raises several controversies; The aim of our study is to evaluate Vitamin D status in Moroccan type 2 diabetic women (DT2) by comparing it with a non-diabetic group (T). Secondary purpose was to establish relationships between Vitamine D status and T2D patients various metabolic, clinical and therapeutic parameters. Materials and Methods : This a cross-sectional case-control study including 110 patients with a Vitamin D dose (60 DT2 / 50 controls> 30 years). We excluded patients with a disease involving phosphocalcic metabolism or receiving Vitamin D supplementation or advanced renal or hepatic failure. Variables studied in the DT2 group were age, diabetes duration, glycemic equilibrium, BMI, degenerative complications, antidiabetic treatment, the menopause and vitamin D. Results were compared to a non-diabetic control group according to age, BMI and menopausal status. Results : Mean age was 51.5 ± 10.95 (DT2) vs 48.9 ± 11.2 years (T). Mean DT2 BMI was 32.1 vs 27.7 Kg / m 2 . Mean diabetes duration was 7.13 years with mean HBA1c at 9.17%. Hypovitaminosis D was present in 85% DT2, these results were comparable to the control group (84%). Mean level of Vitamin D was lower in the DT2 group: 17 ± 10.6 vs 22.2 ± 11.4 ng / ml (p = 0.005). 39% of TD2 were deficient vs 23% (T) p 35kg / m 2 (p= 0.003) with no significant relationship to age or menopausal status. In the DT2 group, there was a negative correlation between serum vitamin D levels and diabetes duration and BMI. Without relationship with HbA1c, degenerative complications or antidiabetic treatment. Conclusion : Hypovitaminosis D is as frequent in the diabetic population as in non-diabetic patients with lower rates and high prevalence in obese patients with ancient diabetes.
导论:糖尿病与(OH)维生素D状态的关系引起了一些争议;我们研究的目的是通过比较摩洛哥2型糖尿病女性(DT2)与非糖尿病组(T)的维生素D水平,以评估其水平。次要目的是建立维生素D水平与T2D患者各种代谢、临床和治疗参数之间的关系。材料和方法:这是一项横断面病例对照研究,包括110名服用维生素D剂量的患者(60名DT2 / 50名对照组,30岁)。我们排除了涉及磷钙代谢或接受维生素D补充或晚期肾或肝功能衰竭的患者。DT2组研究的变量包括年龄、糖尿病病程、血糖平衡、BMI、退行性并发症、抗糖尿病治疗、绝经和维生素d。根据年龄、BMI和绝经状态与非糖尿病对照组进行比较。结果:平均年龄分别为51.5±10.95 (DT2)和48.9±11.2岁(T),平均DT2 BMI分别为32.1和27.7 Kg / m2。平均糖尿病病程为7.13年,平均HBA1c为9.17%。85%的DT2患者存在维生素D缺乏症,这些结果与对照组(84%)相当。DT2组维生素D的平均水平较低:17±10.6 vs 22.2±11.4 ng / ml (p = 0.005)。39%的TD2缺乏vs 23% (T) p 35kg / m2 (p= 0.003),与年龄或绝经状态无显著关系。在DT2组中,血清维生素D水平与糖尿病持续时间和BMI呈负相关。与HbA1c、退行性并发症或降糖治疗无关。结论:糖尿病人群中维生素D缺乏症的发生率与非糖尿病患者相同,但发病率较低,肥胖合并古发糖尿病患者患病率较高。